The DOI matches its Crossref record; 205 of the 209 references it cites were found in a registry or an index.
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
Open accessAbstract
Alzheimer disease (AD) and Parkinson disease (PD) are the two most common age-related neurodegenerative diseases characterized by prominent neurodegeneration in selective neural systems. Although a small fraction of AD and PD cases exhibit evidence of heritability, among which many genes have been identified, the majority are sporadic without known causes. Molecular mechanisms underlying neurodegeneration and pathogenesis of these diseases remain elusive. Convincing evidence demonstrates oxidative stress as a prominent feature in AD and PD and links oxidative stress to the development of neuronal death and neural dysfunction, which suggests a key pathogenic role for oxidative stress in both AD and PD. Notably, mitochondrial dysfunction is also a prominent feature in these diseases, which is likely to be of critical importance in the genesis and amplification of reactive oxygen species and the pathophysiology of these diseases. In this review, we focus on changes in mitochondrial DNA and mitochondrial dynamics, two aspects critical to the maintenance of mitochondrial homeostasis and function, in relationship with oxidative stress in the pathogenesis of AD and PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been proposed that ROS, which are considered markers of oxidative stress, are generated in the cytoplasm of neurons and can cause damage to key cellular components, including DNA, proteins, and lipids, leading to neuronal dysfunction and death (56, 59, 60).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [60]
Experimental — accuracy not yet measuredIn the citing paper
“An increasing body of research indicates that ROS generation exacerbates α-synuclein misfolding in the brain, resulting in PD and other synaptic proteinopathies [37,38].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [37]
In the citing paper
“In clinical studies, probiotics have been shown to lower the development of α-synuclein aggregates by lowering ROS levels, thereby improving the condition of patients with PD [37,39].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,087
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán‐Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munaín, A. L., Aparicio, S. F., Gil, A. M., Khan, N. L., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,453
Research works printed but not linked: 1
- Bonifati, 2003, Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism, Science, 299, 256, 10.1126/science.1077209 · DOI
Cited by
Sorted by citations
Items 101–200 of 720
Polygala tenuifolia : a source for anti-Alzheimer’s disease drugs
Deng, X., Zhao, S., Liu, X., Han, L., Wang, R., Hao, H., Jiao, Y., Han, S., & Bai, C. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1758732 · Cited by 86
Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing
Ullah, H., & Khan, H. Z. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00422 · Cited by 85
Biological functions of selenium and its potential influence on Parkinson's disease
Ellwanger, J. H., Franke, S. I. R., Bordin, D. L., Prá, D., & Henriques, J. A. P. (2016) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201620150595 · Cited by 88
Alzheimer’s disease: as it was in the beginning
Kozlov, S. O., Afonin, A. М., Evsyukov, I., & Бондаренко, А. Б. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0006 · Cited by 87
Mitochondrial control of cell bioenergetics in Parkinson’s disease
Requejo-Aguilar, R., & Bolaños, J. P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.012 · Cited by 87
How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenario
Arrázola, M. S., Silva-Álvarez, C., & Inestrosa, N. C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00166 · Cited by 80
TRPM7 and its role in neurodegenerative diseases
Sun, Y., Sukumaran, P., Schaar, A., & Singh, B. B. (2015) · Channels · doi:10.1080/19336950.2015.1075675 · Cited by 82
Modeling Alzheimer's disease with non-transgenic rat models
Lecanu, L., & Papadopoulos, V. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt171 · Cited by 83
MIRO GTPases in Mitochondrial Transport, Homeostasis and Pathology
Tang, B. L. (2015) · Cells · doi:10.3390/cells5010001 · Cited by 81
Rekkas, P. V., Wilson, A. A., Lee, V. W. H., Yogalingam, P., Sacher, J., Rusjan, P., Houle, S., Stewart, D. E., Kolla, N. J., Kish, S. J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.250 · Cited by 80
Zhang, H., Du, Y., Zhang, X., Lu, J., & Holmgren, A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5499 · Cited by 80
Rashed, A. A., Rahman, A. Z. A., & Rathi, D.-N. G. (2021) · Molecules · doi:10.3390/molecules26041107 · Cited by 78
Moving towards a systems-based classification of innate immune-mediated diseases
Savic, S., Caseley, E. A., & McDermott, M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0377-5 · Cited by 80
Li, T., Chu, C., Yu, L., Zhai, Q., Wang, S., Zhao, J., Zhang, H., Chen, W., & Tian, F. (2022) · Nutrients · doi:10.3390/nu14214678 · Cited by 76
Hassan, A. T., Kandel, R. S., Mishra, R., Gautam, J., Alaref, A. A., & Jahan, N. (2020) · Cureus · doi:10.7759/cureus.9853 · Cited by 74
Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders
Panzarini, E., Mariano, S., Tacconi, S., Carata, E., Tata, A. M., & Dini, L. (2020) · Nanomaterials · doi:10.3390/nano11010002 · Cited by 76
ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer’s Disease
Patro, S., Ratna, S., Yamamoto, H. A., Ebenezer, A. T., Ferguson, D. S., Kaur, A., McIntyre, B. C., Snow, R., & Solesio, M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011185 · Cited by 76
Zhang, R., Miao, Q.-W., Zhu, C., Zhao, Y., Liu, L., Yang, J., & An, L. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514542645 · Cited by 76
Ergothioneine and its prospects as an anti-ageing compound
Apparoo, Y., Phan, C., Kuppusamy, U. R., & Sabaratnam, V. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111982 · Cited by 73
Song, L., Li, H., Fu, X., Cen, M., & Wu, J. L. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.05.014 · Cited by 77
Zhang, J., Culp, M. L., Craver, J., & Darley-Usmar, V. M. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14308 · Cited by 74
Han, K., Jin, X., Guo, X., Cao, G., Tian, S., Song, Y., Zuo, Y., Yu, P., Gao, G., & Chang, Y. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.11.019 · Cited by 73
Valverde-Salazar, V., Ruiz-Gabarre, D., & García‐Escudero, V. (2023) · Antioxidants · doi:10.3390/antiox12071460 · Cited by 76
Yoo, J., Lee, J., Ahn, B., Han, J., & Lim, M. H. (2025) · Chemical Science · doi:10.1039/d4sc06762b · Cited by 78
Meng, X., Sun, G., Ye, J., Xu, H., Wang, H.-Y., & Sun, X. (2014) · Free Radical Research · doi:10.3109/10715762.2014.885117 · Cited by 71
SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model
Zhang, J., Deng, Y., Zhang, M., Su, H., & Qu, Q. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1892-2 · Cited by 70
Succinate dehydrogenase: Prospect for neurodegenerative diseases
Farshbaf, M. J., & Kiani‐Esfahani, A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.12.002 · Cited by 71
Mitochondrial dysfunction in heart failure and its therapeutic implications
Liu, M., Lv, J., Pan, Z., Wang, D., Zhao, L., & Guo, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.945142 · Cited by 75
Thiophenols, Promising Scavengers of Peroxyl Radicals: Mechanisms and kinetics
Carreón-González, M., Vivier‐Bunge, A., & Alvarez-Idaboy, J. R. (2019) · Journal of Computational Chemistry · doi:10.1002/jcc.25862 · Cited by 67
The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health
Qiao, L., Yang, G., Wang, P., & Xu, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107434 · Cited by 73
Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases
Gureev, A. P., & Popov, V. N. (2019) · Neurochemical Research · doi:10.1007/s11064-018-02711-2 · Cited by 65
Hu, X., Niu, Y., Zhang, Q., Tian, X., Gao, L., Guo, L.-P., Meng, W., & Zhao, Q.-C. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.06.017 · Cited by 64
Khan, M. S., Dighe, K., Wang, Z., Srivastava, I., Schwartz‐Duval, A. S., Misra, S. K., & Pan, D. (2018) · The Analyst · doi:10.1039/c8an02085j · Cited by 63
Huang, B., Liu, J., Fu, S., Zhang, Y., Li, Y., He, D., Ran, X., Yan, X., Du, J., Meng, T., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00281 · Cited by 62
Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress
Ciccone, S., Maiani, E., Bellusci, G., Diederich, M. F., & Gonfloni, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022388 · Cited by 67
Aanen, D. K., Spelbrink, J. N., & Beekman, M. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0438 · Cited by 62
Hroch, L., Guest, P. N., Benek, O., Soukup, O., Janočková, J., Doležal, R., Kuča, K., Aitken, L., Smith, T., Gunn‐Moore, F. J., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.029 · Cited by 62
Zhelev, Z., Bakalova, R., Aoki, I., Lazarova, D., & Saga, T. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400159h · Cited by 61
Magnetic Resonance Texture Analysis in Alzheimer's disease
Cai, J., He, Y., Zhong, X., Lei, H., Wang, F., Luo, G.-H., Zhao, H., & Liu, J.-C. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.01.006 · Cited by 66
Type 2 Diabetes (T2DM) and Parkinson’s Disease (PD): a Mechanistic Approach
Sabari, S. S., Balasubramani, K., Iyer, M., Babu, H. W. S., Venkatesan, D., Gopalakrishnan, A. V., Narayanaswamy, A., Kumar, N. S., & Vellingiri, B. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03359-y · Cited by 64
Ginsenoside Rd Protects SH-SY5Y Cells against 1-Methyl-4-phenylpyridinium Induced Injury
Liu, Y., Zhang, R., Zhao, J., Dong, Z., Feng, D., Wu, R. X., Shi, M., & Zhao, G. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160714395 · Cited by 60
Lu, Y., Chen, L., Ye, J., Chen, C., Zhou, Y., Li, K., Zhang, Z., & Peng, M. (2020) · Aging · doi:10.18632/aging.102659 · Cited by 64
Yin, J., Zhang, Y., Liu, X., Li, W., Hu, Y., Zhang, B., & Wang, S. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200739 · Cited by 60
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Hu, J., Zhang, D., Tian, K., Ren, C., Li, H., Lin, C., Huang, X., Liu, J., Mao, W., & Zhang, J. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115475 · Cited by 61
Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease
Ameen‐Ali, K. E., Wharton, S. B., Simpson, J. E., Heath, P. R., Sharp, P. S., & Berwick, J. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12440 · Cited by 59
Reina, M., & Martı́nez, A. (2017) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2017.11.017 · Cited by 59
Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synuclein
Zhang, S., Liu, Z.-L., Wu, H., Hu, Q., Zhang, S., Wang, Y.-M., Jin, Z., Lv, L.-F., Wu, H.-L., & Cheng, O. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.235250 · Cited by 59
A mitochondrial location for haemoglobins—Dynamic distribution in ageing and Parkinson's disease
Shephard, F., Greville‐Heygate, O., Marsh, O., Anderson, S. H., & Chakrabarti, L. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.12.001 · Cited by 59
Cheng, Y., Cawley, N. X., & Loh, Y. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071578 · Cited by 58
Bradshaw, T. Y., Romano, L. E. L., Duncan, E. J., Nethisinghe, S., Abeti, R., Michael, G. J., Giunti, P., Vermeer, S., & Chapple, J. P. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw173 · Cited by 58
Parkin in Parkinson’s Disease and Cancer: a Double-Edged Sword
Wahabi, K., Perwez, A., & Rizvi, M. M. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0879-1 · Cited by 58
Emerging Roles of Sestrins in Neurodegenerative Diseases: Counteracting Oxidative Stress and Beyond
Chen, S., Yang, J., Lin, T., & Yang, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071001 · Cited by 56
Gureev, A. P., Sadovnikova, I. S., Starkov, N. N., Starkov, A. A., & Popov, V. N. (2020) · Brain Sciences · doi:10.3390/brainsci10110847 · Cited by 63
Neopterin as a potential cytoprotective brain molecule
Ghisoni, K., Martins, R. D. P., Barbeito, L., & Latini, A. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.003 · Cited by 56
KDM5 Interacts with Foxo to Modulate Cellular Levels of Oxidative Stress
Liu, X., Greer, C., & Secombe, J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004676 · Cited by 62
Braidy, N., Selvaraju, S., Essa, M., Vaishnav, R., Al-Adawi, S., Al-Asmi, A., Al‐Senawi, H., Alobaidy, A. A. A., Lakhtakia, R., & Guillemin, G. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/685909 · Cited by 65
SanMartín, C. D., Veloso, P., Adasme, T., Lobos, P., Bruna, B., Galaz, J., García, A., Härtel, S., Hidalgo, C., & Paula-Lima, A. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00115 · Cited by 60
Zhang, Y., Ren, S., Liu, Y., Gao, K., Liu, Z., & Zhang, Z. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102146 · Cited by 57
Simpson, J. E., Ince, P. G., Matthews, F. E., Shaw, P. J., Heath, P. R., Brayne, C., Garwood, C., Higginbottom, A., Wharton, S. B., & MRC Cognitive Function and Ageing Neuropathology Study Group (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12202 · Cited by 56
Kaur, H., Bal, A., & Sandhir, R. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.08.001 · Cited by 58
Suri, J. S., Paul, S., Maindarkar, M. A., Puvvula, A., Saxena, S., Saba, L., Turk, M., Laird, J. R., Khanna, N. N., Višković, K., et al. (2022) · Metabolites · doi:10.3390/metabo12040312 · Cited by 60
Datta, S., He, G., Tomilov, A. A., Sahdeo, S., Denison, M. S., & Cortopassi, G. A. (2017) · Environmental Health Perspectives · doi:10.1289/ehp1404 · Cited by 55
Liang, T., Hang, W., Chen, J., Wu, Y., Wen, B., Xu, K., Ding, B., & Chen, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00563-y · Cited by 54
Tang, S., Fuß, A., Fattahi, Z., & Culmsee, C. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07015-8 · Cited by 53
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
Akanji, M. A., Rotimi, D. E., Elebiyo, T. C., Awakan, O. J., & Adeyemı, O. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9971885 · Cited by 55
Volmering, E., Niehusmann, P., Peeva, V., Grote, A., Zsurka, G., Altmüller, J., Nürnberg, P., Becker, A. J., Schoch, S., Elger, C. E., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1561-1 · Cited by 52
Qi, G., Mi, Y., Fan, R., Zhao, B., Ren, B., & Liu, X. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.10.031 · Cited by 55
Jia, G., Aroor, A. R., Martinez‐Lemus, L. A., & Sowers, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1431-3 · Cited by 51
Mitochondria as the Essence of Yang Qi in the Human Body
Luo, J., Shiwei, S., Xia, J., Wang, J., & Gu, Z. (2022) · Phenomics · doi:10.1007/s43657-022-00060-3 · Cited by 52
Ma, W., Hou, C.-C., Zhou, X. J., Yu, H., Xi, Y., Ding, J., Zhao, X., & Xiao, R. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1019-y · Cited by 50
Coumarin–Chalcone Hybrids as Peroxyl Radical Scavengers: Kinetics and Mechanisms
Mazzone, G., Galano, A., Alvarez-Idaboy, J. R., & Russo, N. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00006 · Cited by 50
Agnihotri, S. K., Shen, R., Li, J., Gao, X., & Büeler, H. (2017) · The FASEB Journal · doi:10.1096/fj.201600960rr · Cited by 50
Hericium Erinaceus Prevents DEHP-Induced Mitochondrial Dysfunction and Apoptosis in PC12 Cells
Amara, I., Scuto, M. C., Zappalà, A., Ontario, M. L., Petralia, A., Abid‐Essefi, S., Maiolino, L., Signorile, A., Salinaro, A. T., & Calabrese, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062138 · Cited by 50
Senegenin alleviates Aβ1-42 induced cell damage through triggering mitophagy
Tian, Y., Qi, Y., Cai, H., Xu, M., & Zhang, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115409 · Cited by 49
Trompetero, A., Gordillo, A., del Pilar, M. C., Cristina, V., & Bustos, R. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170828133059 · Cited by 49
Zhou, L., Yao, G., Song, X., Wang, J., Lin, B., Wang, X., Huang, X., & Song, S. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04430 · Cited by 49
Self-citationAnimal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders
Yang, X., Wang, Y., Wu, C., & Ling, E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181031122438 · Cited by 49
Liu, D., Zhao, D., Zhao, Y., Wang, Y., Zhao, Y., & Wen, C. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190503145207 · Cited by 49
Chen, C., Chen, Y. S., Liu, T., Song, D., Ma, D., & Cheng, O. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7511393 · Cited by 47
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
5‐HT1F receptor‐mediated mitochondrial biogenesis for the treatment of Parkinson's disease
Scholpa, N. E., Lynn, M. K., Corum, D. G., Boger, H. A., & Schnellmann, R. G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14076 · Cited by 45
Antioxidative role of Traditional Chinese Medicine in Parkinson's disease
Muhammad, F., Liu, Y., Zhou, Y., Yang, H., & Li, H. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114821 · Cited by 47
Berberine Rescues D-Ribose-Induced Alzheimer‘s Pathology via Promoting Mitophagy
Wang, C., Zou, Q., Pu, Y., Cai, Z., & Tang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065896 · Cited by 45
A comprehensive review of the therapeutic potential of curcumin nanoformulations
Khezri, K., Saeedi, M., Mohammadamini, H., & Zakaryaei, A. S. (2021) · Phytotherapy Research · doi:10.1002/ptr.7190 · Cited by 50
Koklesová, L., Líšková, A., Samec, M., Zhai, K., AL-Ishaq, R. K., Bugos, O., Šudomová, M., Biringer, K., Péč, M. J., Adamkov, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168649 · Cited by 47
Wang, W., Chen, C., Wang, Q., Ma, J., Li, Y., Guan, Z., Wang, R., & Chen, X. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14373 · Cited by 46
Serum Uric Acid Levels in Patients with Alzheimer's Disease: A Meta-Analysis
Chen, X., Guo, X., Huang, R., Chen, Y., Zheng, Z., & Shang, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094084 · Cited by 45
Song, J., Kang, S. M., Lee, W. T., Park, K. A., Lee, K. M., & Lee, J. E. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/639531 · Cited by 45
SanMartín, C. D., Paula-Lima, A. C., GarcÃa, A., Veloso, P., Härtel, S., NÃoñez, M. T., & Hidalgo, C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00013 · Cited by 43
Chen, S., Lin, T., Yang, D., Lee, S.-Y., Shaw, F.-Z., Liou, C., & Chuang, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.045 · Cited by 44
Loss of functional OPA 1 unbalances redox state: implications in dominant optic atrophy pathogenesis
Millet, A. M. C., Bertholet, A. M., Daloyau, M., Reynier, P., Galinier, A., Devin, A., Wissinguer, B., Belenguer, P., & Davezac, N. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.305 · Cited by 44
Petruski‐Ivleva, N., Kucharska‐Newton, A., Palta, P., Couper, D. J., Meyer, K. A., Graff, M., Haring, B., Sharrett, R. A., & HEISS, G. M. (2017) · Nutrients · doi:10.3390/nu9101134 · Cited by 45
Abu‐Elfotuh, K., Hamdan, A. M., Mohammed, A. A., Atwa, A. M., Kozman, M. R., Ibrahim, A. M., Motawea, S. M., Selim, H. M. R. M., Tohamy, S. T. K., El-Din, M. N., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15121554 · Cited by 45
Oxidative and nitrosative stress in serum of patients with Parkinson’s disease
Çubukçu, H. C., Yurtdaş, M., Durak, İ., Aytaç, B., Güneş, H. N., Çokal, B. G., Yoldaş, T. K., & Durak, İ. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2663-1 · Cited by 44
Wang, W., Ma, X., Zhou, L., Liu, J., & Zhu, X. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw430 · Cited by 45
Self-citationXu, S., Yang, X., Qian, Y., & Xiao, Q. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14297 · Cited by 43
Horan, M. P., & Cooper, D. N. (2013) · Human Genetics · doi:10.1007/s00439-013-1402-4 · Cited by 40
Fachal, L., Mosquera‐Miguel, A., Pástor, P., Ortega‐Cubero, S., Lorenzo, E., Durán, A. O., Toriello, M., Quintáns, B., Camiña-Tato, M., Sesar, Á., et al. (2014) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32276 · Cited by 43
Morimoto, T., Chiu, L., Kanda, H., Kawagoe, H., Ozawa, T., Nakamura, M., Nishida, K., Fujita, K., & Fujikado, T. (2019) · The Analyst · doi:10.1039/c8an02213e · Cited by 43
Clementi, M. E., Lazzarino, G., Sampaolese, B., Brancato, A., & Tringali, G. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4170 · Cited by 47
Metadata
- Authors
- Yan, M. H., Wang, X., & Zhu, X.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Wang, Xinglong
- Zhu, Xiongwei
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 62
- Pages
- 90-101
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC3744189
- OpenAlex
- W2027783468
- Cited by
- 718
- References
- 209
- Citations by year
- 2026: 14 · 2025: 34 · 2024: 73 · 2023: 56 · 2022: 69 · 2021: 67 · 2020: 53 · 2019: 47 · 2018: 53 · 2017: 71 · 2016: 54 · 2015: 49 · 2014: 48 · 2013: 30
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- the National Institutes of Health (AG031852, NS071184)
- Alzheimer's Association (IIRG-10–173358)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, Parkinson's disease, mitochondrial dysfunction, oxidative stress, mitochondrial DNA, mitochondrial dynamics, reactive oxygen species, neurodegeneration, mitochondrial homeostasis
- MeSH terms
- Alzheimer Disease, Humans, Mitochondria, Nerve Degeneration, Neurons, Parkinson Disease, Amyloid beta-Peptides, Cell Death, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
